Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paramesh Jangili

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Bioorganic & Medicinal Chemistry Letters|December 5, 2013
Stereoselective total synthesis of a novel regiomer of herbarumin I and its cytotoxic and antimicrobial activitiesParamesh Jangili, Jajula Kashanna, C Ganesh Kumar, et al.
Journal of Medicinal Chemistry|October 23, 2025
Dexamethasone-Appended Activatable Prodrug Overcoming Multidrug ResistanceJungryun Kim, Chong Hu, Paramesh Jangili, et al.
Advanced Materials (Deerfield Beach, Fla.)|September 9, 2020
Fluorescent Diagnostic Probes in Neurodegenerative DiseasesJin Zhou, Paramesh Jangili, Subin Son, et al.
ACS Applied Bio Materials|January 11, 2022
Fluorescent Probe for Monitoring Hydrogen Peroxide in COX-2-Positive Cancer CellsJiyeong Lee, Hyeong Seok Kim, Paramesh Jangili, et al.
Chemical Communications (Cambridge, England)|September 9, 2022
SIWV tetrapeptide and ROS-responsive prodrug conjugate for advanced glioblastoma therapyYoon Kyung Park, Paramesh Jangili, Soyu Zi, et al.
Chemical Society Reviews|July 8, 2020
Cancer stem cell-targeted bio-imaging and chemotherapeutic perspectiveJiyou Han, Miae Won, Ji Hyeon Kim, et al.
ACS Applied Bio Materials|January 11, 2022
Phenylthiourea-Conjugated BODIPY as an Efficient Photosensitizer for Tyrosinase-Positive Melanoma-Targeted Photodynamic TherapyEugeine Jung, Inseob Shim, Jusung An, et al.
Angewandte Chemie (International Ed. in English)|February 8, 2022
DNA-Damage-Response-Targeting Mitochondria-Activated Multifunctional Prodrug Strategy for Self-Defensive Tumor TherapyParamesh Jangili, Na Kong, Ji Hyeon Kim, et al.
ACS Applied Bio Materials|January 15, 2022
Binary Drug Reinforced First Small-Molecule-Based Prodrug for Synergistic Anticancer EffectsParamesh Jangili, Miae Won, Seo Jin Kim, et al.
Angewandte Chemie (International Ed. in English)|September 9, 2025
MitoSiege-Driven Catalase Collapse: A GSH-Responsive, Mitochondria-Targeted COF Prodrug for Amplified Chemodynamic TherapyQihang Ding, Bo Wang, Zixuan Zhan, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Bioorganic & Medicinal Chemistry Letters|December 5, 2013
Stereoselective total synthesis of a novel regiomer of herbarumin I and its cytotoxic and antimicrobial activitiesParamesh Jangili, Jajula Kashanna, C Ganesh Kumar, et al.
Journal of Medicinal Chemistry|October 23, 2025
Dexamethasone-Appended Activatable Prodrug Overcoming Multidrug ResistanceJungryun Kim, Chong Hu, Paramesh Jangili, et al.
Advanced Materials (Deerfield Beach, Fla.)|September 9, 2020
Fluorescent Diagnostic Probes in Neurodegenerative DiseasesJin Zhou, Paramesh Jangili, Subin Son, et al.
ACS Applied Bio Materials|January 11, 2022
Fluorescent Probe for Monitoring Hydrogen Peroxide in COX-2-Positive Cancer CellsJiyeong Lee, Hyeong Seok Kim, Paramesh Jangili, et al.
Chemical Communications (Cambridge, England)|September 9, 2022
SIWV tetrapeptide and ROS-responsive prodrug conjugate for advanced glioblastoma therapyYoon Kyung Park, Paramesh Jangili, Soyu Zi, et al.
Chemical Society Reviews|July 8, 2020
Cancer stem cell-targeted bio-imaging and chemotherapeutic perspectiveJiyou Han, Miae Won, Ji Hyeon Kim, et al.
ACS Applied Bio Materials|January 11, 2022
Phenylthiourea-Conjugated BODIPY as an Efficient Photosensitizer for Tyrosinase-Positive Melanoma-Targeted Photodynamic TherapyEugeine Jung, Inseob Shim, Jusung An, et al.
Angewandte Chemie (International Ed. in English)|February 8, 2022
DNA-Damage-Response-Targeting Mitochondria-Activated Multifunctional Prodrug Strategy for Self-Defensive Tumor TherapyParamesh Jangili, Na Kong, Ji Hyeon Kim, et al.
ACS Applied Bio Materials|January 15, 2022
Binary Drug Reinforced First Small-Molecule-Based Prodrug for Synergistic Anticancer EffectsParamesh Jangili, Miae Won, Seo Jin Kim, et al.
Angewandte Chemie (International Ed. in English)|September 9, 2025
MitoSiege-Driven Catalase Collapse: A GSH-Responsive, Mitochondria-Targeted COF Prodrug for Amplified Chemodynamic TherapyQihang Ding, Bo Wang, Zixuan Zhan, et al.
Pageof 2